The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Cancer biology and NuRD: a multifaceted chromatin remodelling complex
Open accessAbstract
The nucleosome remodelling and histone deacetylase (NuRD; also known as Mi-2) complex regulates gene expression at the level of chromatin. The NuRD complex has been identified — using both genetic and molecular analyses — as a key determinant of differentiation in mouse embryonic stem cells and during development in various model systems. Similar to other chromatin remodellers, such as SWI/SNF and Polycomb complexes, NuRD has also been implicated in the regulation of transcriptional events that are integral to oncogenesis and cancer progression. Emerging molecular details regarding the recruitment of NuRD to specific loci during development, and the modulation of these events in cancer, are used to illustrate how the inappropriate localization of the complex could contribute to tumour biology.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Lysine acetylation targets protein complexes and co-regulates major cellular functions
Choudhary, C., Kumar, C., Gnad, F., Nielsen, M. L., Rehman, M., Walther, T. C., Olsen, J. V., & Mann, M. (2009) · Science · doi:10.1126/science.1175371 · Cited by 4,040
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,730
Self-citationThe Biology of Chromatin Remodeling Complexes
Clapier, C. R., & Cairns, B. R. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.77.062706.153223 · Cited by 2,380
Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation Site Occupancy During Mitosis
Olsen, J. V., Vermeulen, M., Santamaria, A., Kumar, C., Miller, M. L., Jensen, L. J., Gnad, F., Cox, J., Jensen, T. S., Nigg, E. A., et al. (2010) · Science Signaling · doi:10.1126/scisignal.2000475 · Cited by 1,479
Identification and Characterization of a Family of Mammalian Methyl-CpG Binding Proteins
Hendrich, B., & Bird, A. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.11.6538 · Cited by 1,360
Aberrant CpG-island methylation has non-random and tumour-type–specific patterns
Costello, J. F., Frühwald, M. C., Smiraglia, D. J., Rush, L. J., Robertson, G. P., Gao, X., Wright, F. A., Feramisco, J. D., Peltomäki, P., Lang, J. C., et al. (2000) · Nature Genetics · doi:10.1038/72785 · Cited by 1,357
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,275
MLL translocations, histone modifications and leukaemia stem-cell development
Krivtsov, A. V., & Armstrong, S. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2253 · Cited by 1,249
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X.-J., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,230
Xu, G.-L., Bestor, T. H., Bourc'his, D., Hsieh, C.-L., Tommerup, N., Bugge, M., Hulten, M., Qu, X., Russo, J. J., & Viegas-Péquignot, E. (1999) · Nature · doi:10.1038/46052 · Cited by 1,203
Zhang, Y., Ng, H.-H., Erdjument-Bromage, H., Tempst, P., Bird, A., & Reinberg, D. (1999) · Genes & Development · doi:10.1101/gad.13.15.1924 · Cited by 1,103
Xue, Y., Wong, J., Moreno, G. T., Young, M. K., Côté, J., & Wang, W. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80299-3 · Cited by 985
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Zhang, Y., LeRoy, G., Seelig, H.-P., Lane, W. S., & Reinberg, D. (1998) · Cell · doi:10.1016/s0092-8674(00)81758-4 · Cited by 816
Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation
Wade, P. A., Gegonne, A., Jones, P. L., Ballestar, E., Aubry, F., & Wolffe, A. P. (1999) · Nature Genetics · doi:10.1038/12664 · Cited by 811
Self-citationATP-Dependent Nucleosome Remodeling
Becker, P. B., & Hörz, W. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135400 · Cited by 789
The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome
Hansen, R. S., Wijmenga, C., Luo, P., Stanek, A. M., Canfield, T. K., Weemaes, C. M. R., & Gartler, S. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14412 · Cited by 735
Histone Deacetylases: Unique Players in Shaping the Epigenetic Histone Code
THIAGALINGAM, S., CHENG, K., LEE, H. J., MINEVA, N., THIAGALINGAM, A., & PONTE, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb05964.x · Cited by 700
Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex
Tong, J. K., Hassig, C. A., Schnitzler, G. R., Kingston, R. E., & Schreiber, S. L. (1998) · Nature · doi:10.1038/27699 · Cited by 692
LSD1 Is a Subunit of the NuRD Complex and Targets the Metastasis Programs in Breast Cancer
Wang, Y., Zhang, H., Chen, Y., Sun, Y., Yang, F., Yu, W., Liang, J., Sun, L., Yang, X., Shi, L., et al. (2009) · Cell · doi:10.1016/j.cell.2009.05.050 · Cited by 692
Chemoproteomics profiling of HDAC inhibitors reveals selective targeting of HDAC complexes
Bantscheff, M., Hopf, C., Savitski, M. M., Dittmann, A., Grandi, P., Michon, A.-M., Schlegl, J., Abraham, Y., Becher, I., Bergamini, G., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1759 · Cited by 659
Histone Deacetylases and SAP18, a Novel Polypeptide, Are Components of a Human Sin3 Complex
Zhang, Y., Iratni, R., Erdjument-Bromage, H., Tempst, P., & Reinberg, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80216-0 · Cited by 578
The SWI/SNF complex and cancer
Reisman, D., Glaros, S., & Thompson, E. A. (2009) · Oncogene · doi:10.1038/onc.2009.4 · Cited by 568
Closely related proteins MBD2 and MBD3 play distinctive but interacting roles in mouse development
Hendrich, B., Guy, J., Ramsahoye, B., Wilson, V. A., & Bird, A. (2001) · Genes & Development · doi:10.1101/gad.194101 · Cited by 536
Chou, D. M., Adamson, B., Dephoure, N. E., Tan, X., Nottke, A. C., Hurov, K. E., Gygi, S. P., Colaiácovo, M. P., & Elledge, S. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012946107 · Cited by 529
Polycomb group proteins: navigators of lineage pathways led astray in cancer
Bracken, A. P., & Helin, K. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2736 · Cited by 523
MTA3, a Mi-2/NuRD Complex Subunit, Regulates an Invasive Growth Pathway in Breast Cancer
Fujita, N., Jaye, D. L., Kajita, M., Geigerman, C., Moreno, C. S., & Wade, P. A. (2003) · Cell · doi:10.1016/s0092-8674(03)00234-4 · Cited by 510
Self-citationCoREST is an integral component of the CoREST- human histone deacetylase complex
You, A., Tong, J. K., Grozinger, C. M., & Schreiber, S. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1454 · Cited by 502
The human Mi-2/NuRD complex and gene regulation
Denslow, S. A., & Wade, P. A. (2007) · Oncogene · doi:10.1038/sj.onc.1210611 · Cited by 478
Self-citationWade, P. A., Jones, P. L., Vermaak, D., & Wolffe, A. P. (1998) · Current Biology · doi:10.1016/s0960-9822(98)70328-8 · Cited by 436
Self-citationThe methyl-CpG binding domain and the evolving role of DNA methylation in animals
Hendrich, B., & Tweedie, S. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00080-5 · Cited by 399
The NuRD component Mbd3 is required for pluripotency of embryonic stem cells
Kaji, K., Caballero, I. M., MacLeod, R., Nichols, J., Wilson, V. A., & Hendrich, B. (2006) · Nature Cell Biology · doi:10.1038/ncb1372 · Cited by 375
Polo, S. E., Kaidi, A., Baskcomb, L., Galanty, Y., & Jackson, S. P. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.188 · Cited by 374 · cited 1×
“Other NuRD complex subunits have also been shown to have post-translational modifications, such as phosphorylation and acetylatio”
BackgroundTranscriptional repression of oestrogen receptor by metastasis-associated protein 1 corepressor
Mazumdar, A., Wang, R.-A., Mishra, S. K., Adam, L., Bagheri-Yarmand, R., Mandal, M., Vadlamudi, R. K., & Kumar, R. (2001) · Nature Cell Biology · doi:10.1038/35050532 · Cited by 364
Bcl11b is required for differentiation and survival of αβ T lymphocytes
Wakabayashi, Y., Watanabe, H., Inoue, J., Takeda, N., Sakata, J., Mishima, Y., Hitomi, J., Yamamoto, T., Utsuyama, M., Niwa, O., et al. (2003) · Nature Immunology · doi:10.1038/ni927 · Cited by 358
Bcl11a is essential for normal lymphoid development
Liu, P., Keller, J. R., Ortiz, M., Tessarollo, L., Rachel, R. A., Nakamura, T., Jenkins, N. A., & Copeland, N. G. (2003) · Nature Immunology · doi:10.1038/ni925 · Cited by 351
Howard, G., Eiges, R., Gaudet, F., Jaenisch, R., & Eden, A. (2008) · Oncogene · doi:10.1038/sj.onc.1210631 · Cited by 343
MBD2/NuRD and MBD3/NuRD, Two Distinct Complexes with Different Biochemical and Functional Properties
Le Guezennec, X., Vermeulen, M., Brinkman, A. B., Hoeijmakers, W. A. M., Cohen, A., Lasonder, E., & Stunnenberg, H. G. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.3.843-851.2006 · Cited by 340
Humphrey, G. W., Wang, Y., Russanova, V. R., Hirai, T., Qin, J., Nakatani, Y., & Howard, B. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007372200 · Cited by 331
Histone chaperones, a supporting role in the limelight
Loyola, A., & Almouzni, G. (2004) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.09.012 · Cited by 331
MTA3 and the Mi-2/NuRD Complex Regulate Cell Fate during B Lymphocyte Differentiation
Fujita, N., Jaye, D. L., Geigerman, C., Akyildiz, A., Mooney, M. R., Boss, J. M., & Wade, P. A. (2004) · Cell · doi:10.1016/j.cell.2004.09.014 · Cited by 328
Self-citationThe BCL11 gene family: involvement of BCL11A in lymphoid malignancies
Satterwhite, E., Sonoki, T., Willis, T. G., Harder, L., Nowak, R., Arriola, E. L., Liu, H., Price, H. P., Gesk, S., Steinemann, D., et al. (2001) · Blood · doi:10.1182/blood.v98.12.3413 · Cited by 314
SWI2/SNF2 and Related Proteins: ATP-Driven Motors That Disrupt-Protein–DNA Interactions?
Pazin, M. J., & Kadonaga, J. T. (1997) · Cell · doi:10.1016/s0092-8674(00)81918-2 · Cited by 305
A truncating mutation of HDAC2 in human cancers confers resistance to histone deacetylase inhibition
Ropero, S., Fraga, M. F., Ballestar, E., Hamelin, R., Yamamoto, H., Boix-Chornet, M., Caballero, R., Alaminos, M., Setien, F., Paz, M. F., et al. (2006) · Nature Genetics · doi:10.1038/ng1773 · Cited by 290
The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis
Fu, J., Qin, L., He, T., Qin, J., Hong, J., Wong, J., Liao, L., & Xu, J. (2011) · Cell Research · doi:10.1038/cr.2010.118 · Cited by 286
Ageing-related chromatin defects through loss of the NURD complex
Pegoraro, G., Kubben, N., Wickert, U., Göhler, H., Hoffmann, K., & Misteli, T. (2009) · Nature Cell Biology · doi:10.1038/ncb1971 · Cited by 276
The E7 oncoprotein associates with Mi2 and histone deacetylase activity to promote cell growth
Brehm, A., Nielsen, S. J., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J., & Kouzarides, T. (1999) · The EMBO Journal · doi:10.1093/emboj/18.9.2449 · Cited by 267
The Chromatin Remodeler Mi-2β Is Required for CD4 Expression and T Cell Development
Williams, C. J., Naito, T., Arco, P. G.-D., Seavitt, J. R., Cashman, S. M., De Souza, B., Qi, X., Keables, P., Von Andrian, U. H., & Georgopoulos, K. (2004) · Immunity · doi:10.1016/j.immuni.2004.05.005 · Cited by 266
Cancer DNA Methylation: Molecular Mechanisms and Clinical Implications
McCabe, M. T., Brandes, J. C., & Vertino, P. M. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2784 · Cited by 263
FOG‐1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA‐1
Hong, W., Nakazawa, M., Chen, Y., Kori, R., Vakoc, C. R., Rakowski, C., & Blobel, G. A. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600703 · Cited by 253
Targeting of Ikaros to pericentromeric heterochromatin by direct DNA binding
Cobb, B. S., Morales-Alcelay, S., Kleiger, G., Brown, K. E., Fisher, A. G., & Smale, S. T. (2000) · Genes & Development · doi:10.1101/gad.816400 · Cited by 252
The NuRD chromatin–remodeling complex regulates signaling and repair of DNA damage
Smeenk, G., Wiegant, W. W., Vrolijk, H., Solari, A. P., Pastink, A., & van Attikum, H. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201001048 · Cited by 243
The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage
Larsen, D. H., Poinsignon, C., Gudjonsson, T., Dinant, C., Payne, M. R., Hari, F. J., Rendtlew Danielsen, J. M., Menard, P., Sand, J. C., Stucki, M., et al. (2010) · Journal of Cell Biology · doi:10.1083/jcb.200912135 · Cited by 240
Structural Basis for the Recognition of Histone H4 by the Histone-Chaperone RbAp46
Murzina, N. V., Pei, X.-Y., Zhang, W., Sparkes, M., Vicente-Garcia, J., Pratap, J. V., McLaughlin, S. H., Ben-Shahar, T. R., Verreault, A., Luisi, B. F., et al. (2008) · Structure · doi:10.1016/j.str.2008.05.006 · Cited by 213
Toh, Y., & Nicolson, G. L. (2009) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9233-8 · Cited by 207
Yoo, Y., Kong, G., & Lee, M. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601025 · Cited by 200
Magdinier, F., & Wolffe, A. P. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101617298 · Cited by 197
Saito, M., & Ishikawa, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203455200 · Cited by 190
Yoshida, T., Hazan, I., Zhang, J., Ng, S. Y., Naito, T., Snippert, H. J., Heller, E. J., Qi, X., Lawton, L. N., Williams, C. J., et al. (2008) · Genes & Development · doi:10.1101/gad.1642808 · Cited by 181
Deficiency of Mbd2 suppresses intestinal tumorigenesis
Sansom, O. J., Berger, J., Bishop, S. M., Hendrich, B., Bird, A., & Clarke, A. R. (2003) · Nature Genetics · doi:10.1038/ng1155 · Cited by 176
BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter
Cismasiu, V. B., Adamo, K., Gecewicz, J., Duque, J., Lin, Q., & Avram, D. (2005) · Oncogene · doi:10.1038/sj.onc.1208904 · Cited by 176
Mansfield, R. E., Musselman, C. A., Kwan, A. H., Oliver, S. S., Garske, A. L., Davrazou, F., Denu, J. M., Kutateladze, T. G., & Mackay, J. P. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.208207 · Cited by 174
JNK signalling modulates intestinal homeostasis and tumourigenesis in mice
Sancho, R., Nateri, A. S., de Vinuesa, A. G., Aguilera, C. N., Nye, E. L., Spencer‐Dene, B., & Behrens, A. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.153 · Cited by 163
The dMi‐2 chromodomains are DNA binding modules important for ATP‐dependent nucleosome mobilization
Bouazoune, K., Mitterweger, A., Längst, G., Imhof, A., Akhtar, A., Becker, P. B., & Brehm, A. (2002) · The EMBO Journal · doi:10.1093/emboj/21.10.2430 · Cited by 157
Nicolson, G. L., Nawa, A., Toh, Y., Taniguchi, S., Nishimori, K., & Moustafa, A. S. (2003) · Clinical & Experimental Metastasis · doi:10.1023/a:1022534217769 · Cited by 156
Gao, H., Lukin, K., Ramírez, J. A., Fields, S., Lopez, D., & Hagman, J. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809485106 · Cited by 142
Egr1 Transcription Factor: Multiple Roles in Prostate Tumor Cell Growth and Survival
Adamson, E. D., & Mercola, D. (2002) · Tumor Biology · doi:10.1159/000059711 · Cited by 139
c-Jun N-terminal phosphorylation antagonises recruitment of the Mbd3/NuRD repressor complex
Aguilera, C., Nakagawa, K., Sancho, R., Chakraborty, A., Hendrich, B., & Behrens, A. (2010) · Nature · doi:10.1038/nature09607 · Cited by 137
MTA1, a transcriptional activator of breast cancer amplified sequence 3
Gururaj, A. E., Singh, R. R., Rayala, S. K., Holm, C., den Hollander, P., Zhang, H., Balasenthil, S., Talukder, A. H., Landberg, G., & Kumar, R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0601989103 · Cited by 125
Binding of the CHD4 PHD2 finger to histone H3 is modulated by covalent modifications
Musselman, C. A., Mansfield, R. E., Garske, A. L., Davrazou, F., Kwan, A. H., Oliver, S. S., O’Leary, H., Denu, J. M., Mackay, J. P., & Kutateladze, T. G. (2009) · Biochemical Journal · doi:10.1042/bj20090870 · Cited by 124
Morey, L., Brenner, C., Fazi, F., Villa, R., Gutiérrez, A., Buschbeck, M., Nervi, C., Minucci, S., Fuks, F., & Croce, L. D. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00467-08 · Cited by 124
Metastasis-associated protein 1 (MTA1) is an essential downstream effector of the c-MYC oncoprotein
Zhang, X.-Y., DeSalle, L. M., Patel, J. H., Capobianco, A. J., Yu, D., Thomas‐Tikhonenko, A., & McMahon, S. B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502330102 · Cited by 121
Dürr, H., Flaus, A., Owen‐Hughes, T., & Hopfner, K. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl540 · Cited by 117
Srinivasan, R., Mager, G. M., Ward, R. M., Mayer, J. A., & Svaren, J. P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600775200 · Cited by 116
Mechanisms of Disease: methyl-binding domain proteins as potential therapeutic targets in cancer
Sansom, O. J., Maddison, K., & Clarke, A. R. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0812 · Cited by 113
Kim, M. S., Chung, N. G., Kang, M. R., Yoo, N. J., & Lee, S. H. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.03819.x · Cited by 108
Marc, B., Boeke, J., Zhang, R., & Renkawitz, R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207467200 · Cited by 105
Zhang, H., Stephens, L. C., & Kumar, R. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1519 · Cited by 103
Ramírez, J. A., & Hagman, J. R. (2009) · Epigenetics · doi:10.4161/epi.4.8.10108 · Cited by 99
Naito, T., Arco, P. G., Williams, C. J., & Georgopoulos, K. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.008 · Cited by 92
E3 ubiquitin ligase COP1 regulates the stability and functions of MTA1
Li, D., Ohshiro, K., Reddy, S. D. N., Pakala, S. B., Lee, M., Zhang, Y., Rayala, S. K., & Kumar, R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908027106 · Cited by 91
Defective B-cell-negative selection and terminal differentiation in the ICF syndrome
Blanco-Betancourt, C., Moncla, A., Milili, M., Jiang, Y., Viégas-Pèquignot, E., Roquelaure, B., Thuret, I., & Schiff, C. (2003) · Blood · doi:10.1182/blood-2003-08-2632 · Cited by 91
Inhibition of BCL11B expression leads to apoptosis of malignant but not normal mature T cells
Grabarczyk, P., Przybylski, G. K., Depke, M., Völker, U., Bahr, J., Assmus, K., Bröker, B. M., Walther, R., & Schmidt, C. A. (2006) · Oncogene · doi:10.1038/sj.onc.1210152 · Cited by 84
Identification and Functional Characterization of the p66/p68 Components of the MeCP1 Complex
Feng, Q. F., Cao, R., Xia, L., Erdjument‐Bromage, H., Tempst, P., & Zhang, Y. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.2.536-546.2002 · Cited by 82
FOG‐1‐mediated recruitment of NuRD is required for cell lineage re‐enforcement during haematopoiesis
Gao, Z., Huang, Z., Olivey, H. E., Gurbuxani, S. K., Crispino, J. D., & Svensson, E. C. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.368 · Cited by 80
p66 and p66 of the Mi-2/NuRD complex mediate MBD2 and histone interaction
Marc, B., Gong, Z., Leers, J., & Renkawitz, R. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj437 · Cited by 80
MTA1-mediated transcriptional repression of BRCA1 tumor suppressor gene
Molli, P. R., Singh, R. R., Lee, S. W., & Kumar, R. (2007) · Oncogene · doi:10.1038/sj.onc.1210839 · Cited by 73
Identification of Pax5 as a Target of MTA1 in B-Cell Lymphomas
Balasenthil, S., Gururaj, A. E., Talukder, A. H., Bagheri‐Yarmand, R., Arrington, T., Haas, B. J., Braisted, J. C., Kim, I., Lee, N. H., & Kumar, R. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0750 · Cited by 70
ZIP: a novel transcription repressor, represses EGFR oncogene and suppresses breast carcinogenesis
Li, R., Zhang, H., Yu, W., Chen, Y., Gui, B., Liang, J., Wang, Y., Sun, L., Yang, X., Zhang, Y., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.211 · Cited by 63
Another Tie that Binds the MTA Family to Breast Cancer
Kumar, R. (2003) · Cell · doi:10.1016/s0092-8674(03)00274-5 · Cited by 61
Roche, A. E., Bassett, B. J., Samant, S. A., Wei, H., Blobel, G. A., & Svensson, E. C. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2007.10.023 · Cited by 55
MTA1 Coregulator Regulates p53 Stability and Function
Li, D.-Q., Reddy, S. D. N., Pakala, S. B., Wu, X., Zhang, Y., Rayala, S. K., & Kumar, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056499 · Cited by 54
Zhu, D., Fang, J., Li, Y., & Zhang, J. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007684 · Cited by 53
Metastasis-associated protein 1 inhibits p53-induced apoptosis
Moon, H.-E., Cheon, H., & Lee, M. (2007) · Oncology Reports · doi:10.3892/or.18.5.1311 · Cited by 53
Binding of the CHD4 PHD2 Finger to Histone H3 is Modulated by Covalent Modifications
Musselman, C. A., Mansfield, R. E., Garske, A. L., Davrazou, F., Kwan, A. H., Oliver, S. S., O’Leary, H., Denu, J. M., Mackay, J. P., & Kutateladze, T. G. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2009.12.2587 · Cited by 53
Li, X., Jia, S., Wang, S., Wang, Y., & Meng, A. (2009) · Blood · doi:10.1182/blood-2009-06-227777 · Cited by 52
The Drosophila methyl-DNA binding protein MBD2/3 interacts with the NuRD complex via p55 and MI-2
Marhold, J., Brehm, A., & Kramer, K. (2004) · BMC Molecular Biology · doi:10.1186/1471-2199-5-20 · Cited by 40
Chadwick, L. H., Chadwick, B. P., Jaye, D. L., & Wade, P. A. (2009) · Chromosoma · doi:10.1007/s00412-009-0207-7 · Cited by 40
Self-citationBader, S. A., Walker, M., McQueen, H. A., Sellar, R., Oei, E., Wopereis, S., Zhu, Y., Peter, A., Bird, A. P., & Harrison, D. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206574 · Cited by 34
Jaye, D. L., Iqbal, J., Fujita, N., Geigerman, C., Li, S., Karanam, S., Fu, K., Weisenburger, D., Chan, W., Moreno, C. S., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2199 · Cited by 33
Self-citationKusam, S., & Dent, A. L. (2007) · Immunologic Research · doi:10.1007/bf02697368 · Cited by 18
Genetic and epigenetic analyses of MBD3 in colon and lung cancer
Zhu, Y., Harrison, D. J., & Bader, S. A. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601776 · Cited by 17
Cited by
Mechanisms of action and regulation of ATP-dependent chromatin-remodelling complexes
Clapier, C. R., Iwasa, J., Cairns, B. R., & Peterson, C. L. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.26 · Cited by 1,305
Interplay between the Cancer Genome and Epigenome
Shen, H., & Laird, P. W. (2013) · Cell · doi:10.1016/j.cell.2013.03.008 · Cited by 910
Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci
Study, T. P., Schumacher, F. R., (APCB), A. P. C. B., Study, T. I., Canary PASS Investigators, Breast and Prostate Cancer Cohort Consortium (BPC3), The PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, (CAPS), C. O. T. P. I. S., Prostate Cancer Genome-wide Association Study of Uncommon Susceptibility Loci (PEGASUS), The Genetic Associations and Mechanisms in Oncology (GAME-ON)/Elucidating Loci Involved in Prostate Cancer Susceptibility (ELLIPSE) Consortium, et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0142-8 · Cited by 902
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
Epigenetic modifications in cancer
Kanwal, R., & Gupta, S. (2012) · Clinical Genetics · doi:10.1111/j.1399-0004.2011.01809.x · Cited by 550
Metadata
- Authors
- Lai, A. Y., & Wade, P. A.
- Venue
- Nature Reviews Cancer
- Published
- 2011-07-07
- Volume
- 11
- Issue
- 8
- Pages
- 588-596
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2089263351
- Cited by
- 539
- References
- 105
- FWCI
- 2.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.